This cytokine induces epithelial-to-mesenchymal trans-differentiation with increased IL33 gene expression in the cancer cells; this is possibly the mechanism behind the correlation between IL33 expression in malignant and stroma cells and between high IL33 expression and high TNM stage/poor prognosis. This evidence concerns the gene IL33 and cancer.